LISA DOCKERY: Open Payments
NPI 1912760737 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 48 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $60 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $205 |
| ABBVIE INC. | 16 | $173 |
| Corcept Therapeutics | 3 | $54 |
| PFIZER INC. | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, VRAYLAR, Korlym, ELIQUIS, XIFAXAN, CAPLYTA, Rybelsus, QULIPTA.
Industry payments across GA — which companies pay providers there.
